ATE369425T1 - Antikörper gegen eine lar-phosphatase untereinheit - Google Patents

Antikörper gegen eine lar-phosphatase untereinheit

Info

Publication number
ATE369425T1
ATE369425T1 AT99923958T AT99923958T ATE369425T1 AT E369425 T1 ATE369425 T1 AT E369425T1 AT 99923958 T AT99923958 T AT 99923958T AT 99923958 T AT99923958 T AT 99923958T AT E369425 T1 ATE369425 T1 AT E369425T1
Authority
AT
Austria
Prior art keywords
antibodies
lar
phosphatase subunit
subunit
phosphatase
Prior art date
Application number
AT99923958T
Other languages
English (en)
Inventor
Hiroshi Yamamoto
Kazutake Tsujikawa
Yukiko Uchino
Noboru Konishi
Original Assignee
Fuso Pharmaceutical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuso Pharmaceutical Ind filed Critical Fuso Pharmaceutical Ind
Application granted granted Critical
Publication of ATE369425T1 publication Critical patent/ATE369425T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99923958T 1998-06-08 1999-06-07 Antikörper gegen eine lar-phosphatase untereinheit ATE369425T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9802542 1998-06-08

Publications (1)

Publication Number Publication Date
ATE369425T1 true ATE369425T1 (de) 2007-08-15

Family

ID=14208367

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99923958T ATE369425T1 (de) 1998-06-08 1999-06-07 Antikörper gegen eine lar-phosphatase untereinheit

Country Status (9)

Country Link
US (3) US6846912B1 (de)
EP (2) EP1460132A1 (de)
JP (1) JP3991327B2 (de)
KR (1) KR100501550B1 (de)
AT (1) ATE369425T1 (de)
AU (1) AU752642B2 (de)
CA (1) CA2329776C (de)
DE (1) DE69936780T2 (de)
WO (1) WO1999064591A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1097944B1 (de) * 1998-07-10 2008-10-15 Fuso Pharmaceutical Industries Ltd. Antikörper gegen intrazelluläre domänen der protein tyrosin phosphatase
WO2003005953A2 (en) 2001-07-12 2003-01-23 Immunex Corporation Viral proteins capable of binding lar
WO2003079332A1 (fr) * 2002-03-18 2003-09-25 Hitachi Maxell, Ltd. Support d'enregistrement magnetique et cartouche d'enregistrement magnetique
US7622117B2 (en) 2002-04-17 2009-11-24 Dynamis Therapeutics, Inc. 3-deoxyglucosone and skin
JP4852046B2 (ja) * 2004-10-12 2012-01-11 クルセル ホランド ベー ヴェー 癌の治療及び検出に用いる結合分子
WO2008058018A2 (en) 2006-11-02 2008-05-15 Mayo Foundation For Medical Education And Research Predicting cancer outcome
WO2009100214A2 (en) * 2008-02-05 2009-08-13 The Johns Hopkins University Induction of thyroid iodide-handling gene expression in human cancers
AU2009253675A1 (en) 2008-05-28 2009-12-03 Genomedx Biosciences, Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
US10407731B2 (en) 2008-05-30 2019-09-10 Mayo Foundation For Medical Education And Research Biomarker panels for predicting prostate cancer outcomes
GB2512153B (en) 2008-11-17 2014-11-12 Veracyte Inc Methods and compositions of molecular profiling for disease diagnostics
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
US9074258B2 (en) 2009-03-04 2015-07-07 Genomedx Biosciences Inc. Compositions and methods for classifying thyroid nodule disease
JP5392707B2 (ja) * 2009-03-31 2014-01-22 株式会社Ｎｔｔドコモ 膜小胞分裂システム
WO2010124372A1 (en) 2009-04-29 2010-11-04 Genomedx Biosciences, Inc. Systems and methods for expression-based classification of thyroid tissue
EP3360978A3 (de) 2009-05-07 2018-09-26 Veracyte, Inc. Verfahren zur diagnose von schilddrüsenerkrankungen
US10446272B2 (en) 2009-12-09 2019-10-15 Veracyte, Inc. Methods and compositions for classification of samples
US8708914B2 (en) 2010-06-07 2014-04-29 Atheropoint, LLC Validation embedded segmentation method for vascular ultrasound images
US8532360B2 (en) 2010-04-20 2013-09-10 Atheropoint Llc Imaging based symptomatic classification using a combination of trace transform, fuzzy technique and multitude of features
US8639008B2 (en) * 2010-04-20 2014-01-28 Athero Point, LLC Mobile architecture using cloud for data mining application
US8313437B1 (en) 2010-06-07 2012-11-20 Suri Jasjit S Vascular ultrasound intima-media thickness (IMT) measurement system
US8485975B2 (en) 2010-06-07 2013-07-16 Atheropoint Llc Multi-resolution edge flow approach to vascular ultrasound for intima-media thickness (IMT) measurement
EP2569626B1 (de) 2010-05-11 2019-11-27 Veracyte, Inc. Verfahren und zusammensetzungen zur diagnose von leiden
US20130267443A1 (en) 2010-11-19 2013-10-10 The Regents Of The University Of Michigan ncRNA AND USES THEREOF
US10513737B2 (en) 2011-12-13 2019-12-24 Decipher Biosciences, Inc. Cancer diagnostics using non-coding transcripts
WO2013123097A1 (en) 2012-02-13 2013-08-22 SkyKick, Inc. Migration project automation, e.g., automated selling, planning, migration and configuration of email systems
EP2885640B1 (de) 2012-08-16 2018-07-18 Genomedx Biosciences, Inc. Prostatakrebsprognostik mittels biomarkern
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
BR112015022490A2 (pt) 2013-03-15 2017-07-18 Veracyte Inc métodos e composições para classificação de amostras
US12297505B2 (en) 2014-07-14 2025-05-13 Veracyte, Inc. Algorithms for disease diagnostics
US20170335396A1 (en) 2014-11-05 2017-11-23 Veracyte, Inc. Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
EP3504348B1 (de) 2016-08-24 2022-12-14 Decipher Biosciences, Inc. Verwendung von genomischen signaturen zur vorhersage des ansprechens von patienten mit prostatakrebs auf postoperative strahlentherapie
WO2018132916A1 (en) 2017-01-20 2018-07-26 Genomedx Biosciences, Inc. Molecular subtyping, prognosis, and treatment of bladder cancer
CA3055925A1 (en) 2017-03-09 2018-09-13 Decipher Biosciences, Inc. Subtyping prostate cancer to predict response to hormone therapy
AU2018266733A1 (en) 2017-05-12 2020-01-16 Veracyte, Inc. Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness
EP3630836A1 (de) 2017-05-31 2020-04-08 Elstar Therapeutics, Inc. Multispezifische moleküle, die an myeloproliferatives leukämie (mlp)-protein binden, und deren verwendungen
US11217329B1 (en) 2017-06-23 2022-01-04 Veracyte, Inc. Methods and systems for determining biological sample integrity
WO2019028285A2 (en) 2017-08-04 2019-02-07 Genomedx, Inc. USE OF SPECIFIC GENE EXPRESSION OF IMMUNE CELLS FOR THE PROGNOSIS OF PROSTATE CANCER AND THE PREDICTION OF SENSITIVITY TO RADIOTHERAPY

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752583A (en) 1984-11-29 1988-06-21 The United States Of America As Represented By The United States Department Of Energy Monoclonal antibodies to human hemoglobin S and cell lines for the production thereof
US5631151A (en) 1988-10-03 1997-05-20 Biosource Technologies, Inc. Melanin production by transformed organisms
US5888794A (en) 1990-07-11 1999-03-30 New York University Receptor-type phosphotyrosine phosphatase-alpha
US5538886A (en) * 1990-07-11 1996-07-23 New York University Receptor-type phosphotyrosine phosphatase-alpha
US5480972A (en) 1992-10-30 1996-01-02 The University Of Melbourne Allergenic proteins from Johnson grass pollen
UA58482C2 (uk) 1994-06-08 2003-08-15 Бьорінгер Інгельхайм Інтернаціональ Гмбх Моноклональне антитіло vff-18 проти сd44v6 і його фрагменти
US5646333A (en) 1994-09-02 1997-07-08 Drexel University Plant promoter useful for directing the expression of foreign proteins to the plant epidermis
EP1097944B1 (de) * 1998-07-10 2008-10-15 Fuso Pharmaceutical Industries Ltd. Antikörper gegen intrazelluläre domänen der protein tyrosin phosphatase

Also Published As

Publication number Publication date
EP1092772A4 (de) 2004-07-07
EP1460132A1 (de) 2004-09-22
EP1092772B1 (de) 2007-08-08
WO1999064591A1 (en) 1999-12-16
US7358061B2 (en) 2008-04-15
AU4060399A (en) 1999-12-30
AU752642B2 (en) 2002-09-26
CA2329776C (en) 2009-02-10
DE69936780D1 (de) 2007-09-20
US20050026232A1 (en) 2005-02-03
JP3991327B2 (ja) 2007-10-17
US6846912B1 (en) 2005-01-25
US20050008645A1 (en) 2005-01-13
EP1092772A1 (de) 2001-04-18
CA2329776A1 (en) 1999-12-16
US20050042222A1 (en) 2005-02-24
KR20010052712A (ko) 2001-06-25
DE69936780T2 (de) 2008-06-05
KR100501550B1 (ko) 2005-07-18

Similar Documents

Publication Publication Date Title
ATE369425T1 (de) Antikörper gegen eine lar-phosphatase untereinheit
NO20021701L (no) Fremgangsmåte for fremstilling av et konjugat av polyglutamat og et terapeutisk middel
TR199902803T2 (xx) VCAM-1' in te�hisinin daralt�lmas� i�in bile�ikler ve metodlar.
DE3751809D1 (de) Intraoperative erstellung des befundes und tumor-therapie mittels endoskop
ATE238553T1 (de) Krebsbehandlung
BR9912007A (pt) Composições e métodos para terapia e diagnóstico de câncer de próstata
BR0010702A (pt) Novas quinonas como terapias de doenças
ATE517125T1 (de) ANTIKÖRPER GEGEN ßDEATH RECEPTOR 4ß (DR4) UND DEREN VERWENDUNGEN
AU2003205077A1 (en) Imaging agents and methods of imaging naaladase of psma
PT1157041E (pt) Anticorpos para terapia e diagnostico de cancro
BR0012069A (pt) Composições e métodos para a terapia e diagnóstico de câncer pulmonar
CY1116265T1 (el) Kit ραδιοεπισημανσης και προσδιορισμος δεσμευσης
ATE364618T1 (de) Antikörper gegen das muc18-antigen
DE60226499D1 (de) Verwendung von antikörpern gegen das muc18-antigen
WO2004031411A3 (en) Genes and polypeptides relating to human pancreatic cancers
MXPA04000080A (es) Metodos de diagnostico de cancer en la vejiga, composiciones y metodos de rastreo de moduladores de cancer en la vejiga.
BR0009537A (pt) Composições para tratamento e diagnóstico de câncer de mama e métodos para seu uso
ATE400587T1 (de) Gegen das prostata-stammzellantigen (psca) gerichtete antikörper und deren verwendung
PT1135467E (pt) Psca: antigénio de células estaminais da próstata e suas utilizações
EA200100224A1 (ru) Комбинированная терапия в-клеточных лимфом, предусматривающая введение антитела против cd20
NO331101B1 (no) In vitro-fremgangsmate for a uttrykke et antigenmolekyl og antigenmolekyl og et fotosensibiliserende middel for anvendelse ved uttrykking av antigenmolekylet.
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
DE602004023183D1 (de) Gegen antikörper gerichtete photodynamische therapie
DE60014064D1 (de) Einetenascin-c isoform als marker für neoplasmen
ATE493658T1 (de) Gegen menschliches mitochondriales adenylate kinase isozym gerichteter antikörper, zusammensetzung und kit zur diagnose von herzerkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties